IMM Immupharma Plc

TIDMIMM

RNS Number : 4832E

Immupharma PLC

09 February 2018

9 February 2018

ImmuPharma PLC

("ImmuPharma" or the "Company")

Holding in Company

ImmuPharma PLC (LSE: IMM), the specialist drug discovery and development company, announces that on 8 February 2018 it received notification that Alto Invest no longer holds a notifiable interest in the Company.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

For further information, please contact:

 
 ImmuPharma plc (www.immupharma.com)     +44 (0) 207 152 
  Tim McCarthy, Chairman                  4080 
  Lisa Baderoon, Head of Investor 
  Relations                               +44 (0) 7721 413 
  lisa.baderoon@immupharma.com            496 
--------------------------------------  ------------------ 
 
   Northland Capital Partners Limited 
   David Hignell, Jamie Sportswood 
   (Corporate Finance)                     +44 (0) 203 861 
   Rob Rees (Corporate Broking)            6625 
--------------------------------------  ------------------ 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLXKLFBVLFZBBK

(END) Dow Jones Newswires

February 09, 2018 09:00 ET (14:00 GMT)

Immupharma (LSE:IMM)
Historical Stock Chart
From Mar 2024 to Apr 2024

Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2023 to Apr 2024